Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
132K
-
Shares change
-
-27.1K
-
Total reported value, excl. options
-
$1.91M
-
Value change
-
-$391K
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$14.42
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q4 2023
6 filings reported holding OGN - Organon & Co. - Common Stock as of Q4 2023.
Organon & Co. - Common Stock (OGN) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 132K shares
of 260M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (33.5M shares), VANGUARD GROUP INC (30.6M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (10.2M shares), STATE STREET CORP (9.44M shares), MORGAN STANLEY (5.86M shares), SOUND SHORE MANAGEMENT INC /CT/ (4.68M shares), CITADEL ADVISORS LLC (4.21M shares), Bank of New York Mellon Corp (4.12M shares), GEODE CAPITAL MANAGEMENT, LLC (3.9M shares), and Slate Path Capital LP (3.58M shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.